146 related articles for article (PubMed ID: 10977484)
1. Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections.
Owens RC
Am J Manag Care; 2000 May; 6(8 Suppl):S442-7. PubMed ID: 10977484
[No Abstract] [Full Text] [Related]
2. Newer fluoroquinolones and the management of respiratory tract infections.
Karchmer AW
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S15. PubMed ID: 10984322
[No Abstract] [Full Text] [Related]
3. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
Stahlmann R; Lode H
MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
[No Abstract] [Full Text] [Related]
4. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?].
Garau J
Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098
[No Abstract] [Full Text] [Related]
5. Respiratory fluoroquinolones: differences in the details.
Mandell LA; Iannini PB; Tillotson GS
Clin Infect Dis; 2004 May; 38(9):1331-2; author reply 1332-3. PubMed ID: 15127351
[No Abstract] [Full Text] [Related]
6. [Trovafloxacin].
Azanza JR; Ollero D; Sádaba B; García Quetglas E
Rev Med Univ Navarra; 1999; 43(1):45-57. PubMed ID: 10386346
[No Abstract] [Full Text] [Related]
7. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
Iakovlev SV; Polushkina NR; Iakovlev VP
Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
[No Abstract] [Full Text] [Related]
8. [Fluoroquinolones in the treatment of respiratory infections].
Stahlmann R
Pneumologie; 1999 Nov; 53(11):521-9. PubMed ID: 10613068
[No Abstract] [Full Text] [Related]
9. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.
Aspinall SL; Metlay JP; Maselli JH; Gonzales R
Am J Manag Care; 2007 May; 13(5):241-8. PubMed ID: 17488189
[TBL] [Abstract][Full Text] [Related]
10. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
Talan DA
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
Jones RN; Pfaller MA
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
[TBL] [Abstract][Full Text] [Related]
12. [Respiratory tract infections. Increasingly more established antibiotics fail].
MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
[No Abstract] [Full Text] [Related]
13. The newer fluoroquinolones.
O'Donnell JA; Gelone SP
Infect Dis Clin North Am; 2004 Sep; 18(3):691-716, x. PubMed ID: 15308282
[TBL] [Abstract][Full Text] [Related]
14. The quinolones: decades of development and use.
Emmerson AM; Jones AM
J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
[TBL] [Abstract][Full Text] [Related]
15. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
[No Abstract] [Full Text] [Related]
16. Summaries for patients. Changing use of antibiotics in community-based outpatient practice, 1991-1999.
Ann Intern Med; 2003 Apr; 138(7):I24. PubMed ID: 12667052
[No Abstract] [Full Text] [Related]
17. [Other communal respiratory pathogens and new fluoroquinolones].
Cantón R; Loza E; Valdezate S; Baquero F
Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():12-21; discussion 47-52. PubMed ID: 10344094
[No Abstract] [Full Text] [Related]
18. [Oral fluoroquinolones. Rational antibiosis as needed].
MMW Fortschr Med; 1999 Sep; 141(35):58-9. PubMed ID: 10897964
[No Abstract] [Full Text] [Related]
19. Antibiotic prescribing for upper respiratory tract infections in children: the role of parental expectations.
Milandri M; Moro ML; Marchi M
J Pediatr; 2005 Nov; 147(5):714; author reply 714-5. PubMed ID: 16291373
[No Abstract] [Full Text] [Related]
20. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
